Related Experiment Video
Updated: Jul 17, 2025
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Biomarkers in heart failure: a focus on natriuretic peptides
Mohamed Eltayeb1, Iain Squire1, Shirley Sze2
1Department of Cardiovascular Sciences and NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
Insights
Natriuretic peptides (NPs) are vital biomarkers for diagnosing and managing heart failure (HF). This review explores their physiology, clinical use in HF assessment, and potential therapeutic applications.
Area of Science:
- Cardiology
- Biochemistry
- Clinical Medicine
Background:
- Heart failure (HF) presents a significant and growing public health challenge, particularly in elderly populations with complex comorbidities.
- Accurate assessment and timely, evidence-based treatment are crucial for preventing hospitalizations and improving outcomes in HF patients.
- Biomarkers have revolutionized HF evaluation and management, with natriuretic peptides (NPs) being extensively studied.
Purpose of the Study:
- To review the physiology and biological effects of natriuretic peptides (NPs).
- To discuss the established and emerging roles of NPs in the diagnosis, management, and prognostication of heart failure (HF).
- To explore the potential of NPs as therapeutic agents in cardiovascular disease.
Main Methods:
- Literature review focusing on natriuretic peptides (NPs) in heart failure (HF).
- Analysis of physiological and biological data related to NP function.
- Synthesis of clinical evidence regarding NP application in HF diagnosis, prognosis, and treatment.
Main Results:
- Natriuretic peptides (NPs) are established clinical tools for guiding HF diagnosis and prognosis.
- NPs play a critical role in the physiological regulation of cardiovascular homeostasis.
- Ongoing research investigates NPs for novel therapeutic strategies in HF management.
Conclusions:
- Natriuretic peptides (NPs) are indispensable in modern heart failure (HF) care, aiding diagnosis, prognosis, and management.
- Understanding NP physiology is key to appreciating their clinical utility.
- Further research into NPs may unlock new therapeutic avenues for HF patients.
Abstract:
While progress has been made in the management of most aspects of cardiovascular disease, the incidence and prevalence of heart failure (HF) remains high. HF affects around a million people in the UK and has a worse prognosis than most cancers. Patients with HF are often elderly with complex comorbidities, making accurate assessment of HF challenging. A timely diagnosis and initiation of evidence-based treatments are key to prevent hospitalisation and improve outcomes in this population. Biomarkers have dramatically impacted the way patients with HF are evaluated and managed. The most studied biomarkers in HF are natriuretic peptides (NPs). Since their discovery in the 1980s, there has been an explosion of work in the field of NPs and they have become an important clinical tool used in everyday practice to guide diagnosis and prognostic assessment of patients with HF. In this article, we will review the physiology of NPs and study their biological effects. Then, we will discuss the role of NPs in the diagnosis, management and prognostication of patients with HF. We will also explore the role of NPs as a potential therapeutic agent.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Heart Failure II: Pathophysiology
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:30Heart Failure VII: Nursing Interventions
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:22Heart Failure Drugs: Diuretics